Ranbaxy gets FDA approval for depression drug
That's Cricket - Washington: India's drug major Ranbaxy Laboratories has received the US Food and Drug Administration (FDA)'s final approval to manufacture and market its formulation for the treatment of major depressive disorders in adults. Ranbaxy Pharmaceuticals
Source: news.indiainfo.com
This week's contents
San Francisco Business Journal - Phase III trial [Monday] Enkata hires first CFO [Monday] Titan, cutting losses, ends year with $13.7M in cash [Monday] PneumRx raises $27M in private placement [Monday] Shorenstein buying more D.C. property [Monday] Impax settles suit over depression drug
Source: sanfrancisco.bizjournals.com
How about men troubled ..
Town Hall - There were greater instances of depression, drug use, suicidal thoughts, and total mental health problems. The authors concluded that their results were consistent “with the view that exposure to abortion was associated with increased risks of
Source: www.townhall.com
Articles 11 to 20 of 48
Wharton - The company faces a dearth of new drugs to replace top sellers due to lost patent protection in the next few years, and has canceled work on a highly anticipated depression drug that failed in late-stage trials. Wharton faculty and outside analysts
Source: knowledge.wharton.upenn.edu
Click here for more information about postpartum depression postpartum depression
